PCN17 COMPARING THE COST-EFFECTIVENESS OF 3 MCG/KG Q2W DARBEPOETIN ALFA WITH STANDARD DOSE EPOETIN ALFA FOR ANEMIA MANAGEMENT IN CHEMOTHERAPY-TREATED CANCER PATIENTS IN UNITED STATES
Nov 1, 2002, 00:00
10.1016/S1098-3015(10)61433-7
https://www.valueinhealthjournal.com/article/S1098-3015(10)61433-7/fulltext
Title :
PCN17 COMPARING THE COST-EFFECTIVENESS OF 3 MCG/KG Q2W DARBEPOETIN ALFA WITH STANDARD DOSE EPOETIN ALFA FOR ANEMIA MANAGEMENT IN CHEMOTHERAPY-TREATED CANCER PATIENTS IN UNITED STATES
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)61433-7&doi=10.1016/S1098-3015(10)61433-7
First page :
Section Title :
Open access? :
No
Section Order :
241